BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 5721943)

  • 1. Pyrazolidines in the treatment of gout.
    Kuzell WC
    Can Med Assoc J; 1968 Nov; 99(21):1038-43. PubMed ID: 5721943
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in the therapy of gout.
    Gutman AB
    J Am Geriatr Soc; 1968 May; 16(5):499-504. PubMed ID: 4296544
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of gout.
    Wallace SL
    Arthritis Rheum; 1972; 15(3):317-23. PubMed ID: 5031616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antarthritics. 41].
    Mayr E
    Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of gout.
    Kersley GD
    Scott Med J; 1973; 18():Suppl 1:249-50. PubMed ID: 4773968
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug control of gout and hyperuricaemia.
    Emmerson BT
    Drugs; 1978 Aug; 16(2):158-66. PubMed ID: 352666
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for gout.
    Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 9. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of primary gout: the present status.
    Gutman AB
    Arthritis Rheum; 1965 Oct; 8(5):911-20. PubMed ID: 5863107
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of gout.
    Gordon GV; Schumacher HR
    Am Fam Physician; 1979 Jan; 19(1):91-7. PubMed ID: 760433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of chronic gout].
    Ballabio CB; Ligmière GC; Famtiori F; Tosi S; Colombo B
    Arzneimittelforschung; 1971 Nov; 21(11):1857-60. PubMed ID: 5171821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic agents for gout effecting the kidney].
    Ueda Y; Kono H; Kobayashi Y; Kagawa K; Yonezawa H
    Geka Chiryo; 1970 Mar; 22(3):317-22. PubMed ID: 5467650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Maintenance therapy of gout].
    Hart FD
    Clin Ter; 1967 Mar; 40(6):511-9. PubMed ID: 5601192
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical management of gout.
    Gutman AB
    Postgrad Med; 1972 May; 51(6):61-6. PubMed ID: 5028822
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of gout.
    Scott JT
    Br Med J; 1969 Aug; 3(5668):456-7. PubMed ID: 5811656
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
    Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of gout.
    McCarty DJ
    Hosp Pract; 1979 Sep; 14(9):75-8, 83-5. PubMed ID: 478531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.